CYC vs IBX

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

CYC

CYCLOPHARM FPO [CYC]

44LOW

IBX

IMAGIONBIO FPO [IBX]

44LOW

Score Breakdown

CYC IBX
Technical
65
61
Catalyst
55
50
Sentiment
50
50
Fundamental
55
11
Momentum
39
62
Risk Gate
50
37

Key Metrics

CYC Metric IBX
$91.8MMarket Cap$10.3M
98KAvg Volume (20d)2.0M
+0.0%Short InterestN/A
$1.47552-Week High$0.055
$0.56052-Week Low$0.011
+6.7%Daily Change+22.2%
$0.800Entry Price$0.022
-49.3%ROEN/A
-53.3%Profit MarginN/A

Active Signals

CYC Signals

●MACD momentum is picking up steam
●Above-average volume (1.7x) on a green day — buyers stepping up
●On a tear — up 11.1% over the last 5 days
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (1.5 quarters)
●Low P/S ratio (2.8x)
●Moderate revenue growth (+18%)
●EPS estimates revised upward (+10pts)

IBX Signals

●MACD just crossed bullish — momentum is shifting to the upside
●Above-average volume (1.8x) on a green day — buyers stepping up
●Watch out — volume is flowing out even as price holds up. Distribution pattern
●On a tear — up 15.8% over the last 5 days
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (1.8 quarters)
●4C filed 2026-01-28
●Very high P/S ratio (141.1x)

Ask Scout AI to compare CYC and IBX in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
CYC Full Analysis → IBX Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).